Institution scientifique

Innovaderm (Canada)

Montreal · CA · company

488Publications signalées

24824Citations signalées

12Thèmes principaux

Principaux domaines

Dermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisSpondyloarthritis Studies and TreatmentsAsthma and respiratory diseasesAllergic Rhinitis and SensitizationUrticaria and Related ConditionsContact Dermatitis and AllergiesFood Allergy and Anaphylaxis ResearchSkin Protection and AgingAutoimmune Bullous Skin DiseasesRheumatoid Arthritis Research and TherapiesIL-33, ST2, and ILC Pathways

Évolution annuelle

20011

20022

20043

20051

20064

20072

20089

200911

201011

201111

20128

20135

201412

201511

201623

201713

201827

201929

202026

202137

202238

202352

202467

202549

202629

Publications récentes

2026 article

Efficacy of abrocitinib and dupilumab on chronic hand eczema in patients with moderate-to-severe atopic dermatitis: a prespecified exploratory analysis of the phase 3 JADE DARE study

Robert Bissonnette, Vivian Shi, Ana Giménez-Arnau, Marie-Noëlle Crépy et autres

0 citationsJournal of the American Academy of Dermatology

Accès ouvert 2026 article

Safety of Icotrokinra Through 1 Year for the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriasis Affecting High-Impact Sites: Pooled Results Across the ICONIC-LEAD, ICONIC-TOTAL, and ICONIC-ADVANCE 1 and 2 Phase 3 Trials

Mark Lebwohl, Melinda Gooderham, Richard B. Warren, Lawrence F. Eichenfield et autres

0 citationsDermatology and Therapy

Accès ouvert 2026 article

EP262, an MRGPRX2 Antagonist for the Treatment of Atopic Dermatitis: Results From the Phase 2 Randomized EASE Study

Shirley Dehn, Daniel Cooper, Christian Weyer, Beatrice Ferguson et autres

0 citationsDermatology and Therapy

2026 review

Placebo Response in Randomised Controlled Trials of Systemic Therapies for Cutaneous Lupus Erythematosus: A Systematic Review and Meta-Analysis

Stéphanie Légaré, Sherry Lin, Sarah Vahey, J.G. Ovalles-Bonilla et autres

0 citationsPharmaceutical Medicine

2026 article

0941 Reduction of skin CD8 TRMs in icotrokinra-treated participants with moderate-to-severe plaque psoriasis: Phase 3 ICONIC-LEAD results through week 52

J. Angsana, Y. Ren, J. Sendecki, K. Kohler et autres

0 citationsJournal of Investigative Dermatology

Accès ouvert 2026 article

Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials

Linda Stein Gold, April W Armstrong, Jennifer Soung, Ronald Vender et autres

2 citationsBritish Journal of Dermatology

2026 article

76957 Efficacy and Safety of Upadacitinib in Adolescents and Adults with Severe Alopecia Areata: A Subgroup Analysis of the UP-AA Phase 3 Clinical Program

Melinda Gooderham, Thierry Passeron, O. Kwon, Diamant Thaçi et autres

0 citationsJournal of the American Academy of Dermatology

2026 article

73228 Durability of Response With Icotrokinra, a Targeted Oral Peptide, in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials

Linda Stein Gold, April W. Armstrong, Jennifer Soung, Ronald Vender et autres

0 citationsJournal of the American Academy of Dermatology

2026 article

70710 Efficacy and safety of deucravacitinib in genital psoriasis: data from a phase 4 study

Robert Bissonnette, Jonathan Barker, Jerry Bagel, Tyring Sk et autres

0 citationsJournal of the American Academy of Dermatology

2026 article

74500 Impact of Disease Duration on the Treatment Effect of Secukinumab in the Prevention of Psoriatic Arthritis in Patients with Moderate to Severe Psoriasis: A 5-year Pooled Analysis of the ERASURE, FIXTURE and SCULPTURE Studies

Diamant Thaçi, Ulrich Mrowietz, Bárður Sigurgeirsson, Richard B. Warren et autres

0 citationsJournal of the American Academy of Dermatology

2026 article

72893 Efficacy and Safety of Tapinarof Cream 1% Once Daily Monotherapy in Adults and Children with Atopic Dermatitis: Pooled Results from ADORING 1 and 2

J H SILVERBERG, Lawrence F. Eichenfield, Linda Stein Gold, Juan Camilo Arjona Ferreira et autres

0 citationsJournal of the American Academy of Dermatology

2026 article

72824 Delgocitinib cream 20 mg/g for moderate to severe Chronic Hand Eczema: outcomes over 16 weeks by prior systemic therapy exposure

Robert Bissonnette, Sibylle Schliemann, Margitta Worm, Luca Stingeni et autres

0 citationsJournal of the American Academy of Dermatology

Identifiant ROR

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.